Company news
Avalo Therapeutics, Inc. news in 2024
Avalo Therapeutics, Inc.'s news releases, calls and decks from 2024, newest first.
Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants
November 11, 2024
Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates
November 6, 2024
Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
October 7, 2024
Avalo Announces Participation in September Investor Conferences
September 3, 2024
Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 11, 2024
Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer
July 15, 2024
Avalo Therapeutics Announces Active IND for AVTX-009, an anti-IL-1β mAb, to Treat Hidradenitis Suppurativa
July 8, 2024
Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer
June 23, 2024
Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit
June 16, 2024
Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
May 12, 2024
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
April 1, 2024
Avalo Reports 2023 Financial Results and Provides Business Updates
March 28, 2024
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
March 26, 2024
Calls in 2024
- Avalo Therapeutics (NASDAQ:AVTX) Q3 2024 Earnings Call
Oct 30, 2024
Transcript - Avalo Therapeutics (NASDAQ:AVTX) Q2 2024 Earnings Call
Jul 31, 2024
Transcript - Avalo Therapeutics (NASDAQ:AVTX) Q1 2024 Earnings Call
May 1, 2024
Transcript - Avalo Therapeutics (NASDAQ:AVTX) Q4 2023 Earnings Call
Feb 28, 2024
Transcript
Decks in 2024
- Investor Presentation (December 2024)
Investor deck · 24 slides · Dec 5, 2024
- Investor Presentation (November 2024)
Investor deck · 26 slides · Nov 12, 2024
- Investor Presentation (October 2024)
Investor deck · 26 slides · Oct 8, 2024
- Investor Presentation (September 2024)
Investor deck · 23 slides · Sep 9, 2024
- Investor Presentation (June 2024)
Investor deck · 25 slides · Jun 24, 2024
- Merger or Acquisition (March 2024)
Merger or acquisition · 25 slides · Mar 28, 2024